OIZUMI Corporation (TSE:6428) Signed a share transfer agreement to acquire Takeuchi Pharmaceutical Co., Ltd from Saju Kanemitsu and 4 other individual shareholders on August 19, 2022. OIZUMI Corporation will acquire 10,000 shares of Takeuchi Pharmaceutical. The transaction is expected to close on August 31, 2022.

OIZUMI Corporation (TSE:6428) completed the acquisition of Takeuchi Pharmaceutical Co., Ltd from Saju Kanemitsu and 4 other individual shareholders on August 31, 2022.